Immune Design

Immune Design adds Carlos Paya as CEO

Wednesday, April 27, 2011

Seattle-based vaccine developer Immune Design’s new CEO is Carlos Paya, the former president of Ireland-based biotech Elan. Paya is replacing Immune Design’s founding CEO, Steve Reed, who will continue to serve on the company’s executive management team and board, according to Xconomy Seattle.

[Read More]